OUR CONTRACT PHARMACEUTICAL SERVICES

Company Overview

PHASE 2 & 3 CLINICAL MANUFACTURING

We are fully equipped and accredited to manufacture a wide range of products for Phase 2 and small-scale Phase 3 trials. We provide a this service to pharmaceutical and biopharmaceutical clients throughout the world.

Read MoreWatch Now

Quay Pharma has the expertise and the capabilities to manage complex formulations under comprehensive regulatory and rigorous quality assurance procedures.

We have in-house GMP capabilities to handle liquid and solid dosage forms, including cytotoxic drugs, hormones, and potent drugs. We also manufacture and supply controlled drug products, and we are one of the limited number of manufacturers in the UK licensed to produce specials.

Using state-of-the-art facilities and supported by our in-house analytics specialists, our experts ensure that products are seamlessly scaled-up and transferred to clinical quantity manufacturing.

We provide comprehensive support to clients through the often complex process of licensing their product or moving on to Phase III or commercial contract manufacture by writing technical transfer packages and offering practical advice whenever required.

Our Production Capabilities Include:

  • Direct compression tablets.
  • Wet granulated tablets.
  • Coating using immediate release and modified release polymers.
  • Spray drying technologies.
  • API layering on to nonpareils.
  • Extrusion, spheronisation and pellet coating.
  • Powder, granule and pellet filled capsules.
  • Liquid and semi-solid fill into capsules.
  • Thermally reversible gels.
  • Ointments and creams.
  • Aqueous and non-aqueous based gels.
  • Aqueous and non aqueous based liquids and syrups for adults and children.
  • Wet and dry suspensions.
  • Nasal sprays.
  • Products for terminal sterilisation, including liquids and gels.
  • Comparator-blinding services, including encapsulation and coating.
  • Placebo development for use in blinded studies.
Your Dedicated Contacts
Maura McArdle
Head of Business Development
(Formulation Development)
Contact

Maura McArdle joined Quay as Head of Business Development for Europe in 2019. Maura’s appointment is to ensure continued focus on Quay’s core business, Pharmaceutical Development of small molecule compounds. With a degree in Chemical Engineering, Maura has over 20 years of business development experience into the Chemical and Pharmaceutical industries having previously worked for Almac, Brenntag and BASF.

Contact
Dr Ivan Langan
Business Development Manager
Contact

A PhD organic synthetic chemist with over 13 years’ experience in the clinical trials industry holding a number of roles within Operations and Business development. Prior to entering the clinical trial industry Ivan had worked in chemical manufacturing. With over 9 years’ experience gained in the manufacturing of API & chemical intermediates, gaining a breadth of knowledge & experience in both batch & continuous manufacture, from kilo to multi tonne scale along with holding a number of managerial positions during this time.

Contact
Our Pharmaceutical Services

Preclinical Formulation

Robust formulation development strategies tailored to the characteristics of each individual API.

Find Out More

Pharmaceutical Preformulation

Analysis of Active Pharmaceutical Ingredients (APIs), including those that present particular challenges.

Find Out More

Pharmaceutical Formulation Development

Dosage form optimisation for a wide range of product types including those that have poor solubility or bioavailability.

Find Out More

Analytical Services

Analytical specialists working alongside our formulation and manufacturing teams which provide expert advice.

Find Out More

Phase I Clinical Manufacturing

Early clinical formulations and clinical manufacturing of First in Human trials and clinical evaluations of your API.

Find Out More

Phase II & III Clinical Manufacturing

Fully equipped and accredited to manufacture a wide range of products for Phase II and small-scale Phase III trials.

Find Out More

Commercial Manufacture & Packaging

MHRA licensed to include commercial manufacture. Services include contract packaging and assembly...

Find Out More

Controlled Substances

Over ten years of extensive development and manufacture experience converting controlled substances into a variety of different dosage forms.

Find Out More

Clinical Trial Supply

Complete range of clinical trial supply packaging for solid and liquid dosages. Despatched with full QP release certification.

Find Out More

Live Biotherapeutics Drug Delivery

One of the few companies licensed for the clinical manufacture of live biotherapeutics products.

Find Out More

Orphan Drugs

Perfectly equipped to deliver an Orphan Drug molecule from preclinical and formulation development to small scale commercialisation.

Find Out More

Specials Manufacturing

One of the limited number of contract manufacturers who hold an MRHA license for the manufacture and supply of ‘specials’.

Find Out More

Let's Talk Project Success

Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.

Contact Us